Results 101 to 110 of about 78,921 (263)

Multicenter, open-label study of the sustained-release formulation of azithromycin (azithromycin SR) for treatment of acute bronchitis and secondary infection of chronic respiratory disease

open access: yes, 2009
マクロライド系抗菌薬であるazithromycin(AZM)の新剤型,経口懸濁液用の徐放性製剤(単回投与製剤)の急性気管支炎および慢性呼吸器疾患の二次感染患者を対象とした第3相,多施設共同,非盲検非対照試験を実施し,AZM単回投与製剤2 g単回経口投与時の有効性および安全性を検討した。 主要評価項目である臨床効果解析対象集団の第8日目の臨床効果(有効率)は,全体で93.3%(42/45例)であり,疾患別では急性気管支炎が97.0%(32/33例),慢性呼吸器疾患の二次感染が83.3%(10/12例 ...
渡辺, 彰   +3 more
core  

Antibiotic‐mediated immune modulation in periodontitis

open access: yesPeriodontology 2000, EarlyView.
Abstract Periodontitis is a chronic inflammatory disease affecting the supporting structures of the teeth. Although initiated by dysbiotic microbial communities, its progression is largely driven by the host's uncontrolled inflammatory response. While antibiotics have conventionally been employed in periodontitis therapy for their antimicrobial ...
Lina J. Suárez   +6 more
wiley   +1 more source

Prevalence of azithromycin resistance after the COVID-19 era in clinical bacterial isolates from a tertiary care hospital in Gurugram, India

open access: yesFrontiers in Microbiology
The increasing prevalence of antibiotic resistance in pathogenic bacteria poses a great healthcare problem worldwide. Azithromycin (AZM) is a very effective macrolide antibiotic to treat many bacterial infections, but increasing azithromycin resistance ...
Parbati Debnath   +6 more
doaj   +1 more source

Topical azithromycin or ofloxacin for endophthalmitis

open access: yes, 2012
Michael W Stewart, Michael L StewartDepartment of Ophthalmology, Mayo Clinic, Jacksonville, FL, USAThe recently published study by Romero-Aroca et al1 raises interesting questions regarding the effect of choice of topical antibiotic (azithromycin versus ...
Stewart MW, Stewart ML
core  

Novel and emerging antimicrobial strategies in the management of oral infections

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Antibiotics marked a pivotal turning point in human civilization, enhancing social interactions and extending human life expectancy. In addition to their success in treating systemic infectious diseases, they have significantly improved periodontal treatment outcomes as an adjunct therapy.
Ozge Unlu, Nil Yakar, Alpdogan Kantarci
wiley   +1 more source

Azithromycin use before and during the COVID- 19 pandemic and the impact of implementing national evidence-based guidelines in Qatar

open access: yesClinical Epidemiology and Global Health
Background: Initial small, uncontrolled studies suggested a beneficial effect of azithromycin in individuals with COVID-19. However, subsequent studies have not confirmed its effectiveness. We assessed azithromycin usage before and during the pandemic in
Adeel A. Butt   +11 more
doaj   +1 more source

Factors influencing the effectiveness of surgical therapy of peri‐implantitis

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Surgical therapy is required in the majority of peri‐implantitis cases due to the inconsistent efficacy of non‐surgical approaches. Although surgical treatment generally offers higher predictability, reported success rates vary widely.
Ausra Ramanauskaite   +3 more
wiley   +1 more source

Azithromycin Prescribing by Respiratory Pediatricians in Australia and New Zealand for Chronic Wet Cough: A Questionnaire-Based Survey

open access: yes, 2020
Aims: To determine how respiratory pediatricians across Australia and New Zealand prescribe azithromycin for children with chronic wet cough, including recurrent protracted bacterial bronchitis, chronic suppurative lung disease (CSLD) and bronchiectasis.
Chang, Anne B   +2 more
core   +1 more source

Periodontitis and metabolic dysfunction‐associated steatotic liver disease

open access: yesPeriodontology 2000, EarlyView.
Abstract Objective Periodontitis is a chronic inflammatory disease with systemic effects that extend beyond the oral cavity and contribute to systemic immune and metabolic dysregulation. Chronic liver diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive phenotypes, have emerged as major global ...
Rafael Scaf de Molon   +6 more
wiley   +1 more source

Flapless submucosal instrumentation treatment of peri‐implantitis: Contemporary evidence and clinical protocol

open access: yesPeriodontology 2000, EarlyView.
Abstract Background/Aim Peri‐implantitis is a plaque‐associated disease characterized by inflammation of the peri‐implant mucosa and progressive loss of supporting bone, representing a growing clinical and public health challenge. Conventional nonsurgical therapies often provide limited and unpredictable outcomes, while surgical approaches are ...
José Nart   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy